Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Medical Imaging›PET Kinetic Modeling
Process / pipelineQuantitative imaging

PET Kinetic Modeling

Positron Emission Tomography Kinetic Modeling · Also known as: PET pharmacokinetics, Dynamic PET, PET compartmental modeling

PET kinetic modeling is a quantitative analysis technique that tracks the temporal behavior of radioactive tracers in tissue to extract physiological parameters such as blood flow, metabolic rate, and receptor density. Established by Patlak, Logan, and Gunn in the 1980s and 1990s, kinetic modeling transforms raw PET time-activity curves into interpretable biological measures. It is widely used in neurology, oncology, and cardiology to assess disease severity, treatment response, and regional tissue function.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 3 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

PET Kinetic Modeling
CT Iterative Reconstruct…DTI TractographyOCT AngiographyQuantitative Susceptibil…RadiomicsDEXAFunctional UltrasoundImaging Mass Cytometry

When to use it

PET kinetic modeling is appropriate when quantitative physiological measurement is required to distinguish disease stages, monitor treatment response, or test mechanistic hypotheses. It is most valuable in neuropsychiatric disorders (Alzheimer disease, Parkinson disease, depression) where tracer kinetics reflect neuropathology, and in oncology where tumor blood flow and glucose metabolism guide therapy. Kinetic modeling is less necessary for simple visual interpretation of PET images, and it requires careful attention to arterial sampling, scanner calibration, and model assumption validation.

Strengths & limitations

Strengths
  • Quantification: converts raw PET counts into standardized physiological parameters (mL/min/g, pmol/mL) independent of scanner, dose, or body weight
  • Mechanistic insight: parameter estimates (K1, ki, binding potential) directly relate to tissue physiology, enabling hypothesis-driven biomarker discovery
  • High sensitivity: kinetic parameters often change earlier than clinical symptoms, enabling preclinical disease detection
  • Flexibility: multiple compartment models accommodate tracers with different kinetics (irreversible, reversible, non-specific binding)
  • Multimodal integration: kinetic parameters can be fused with structural MRI for precise anatomic-functional correlation
Limitations
  • Labor-intensive: requires arterial blood sampling (invasive, requires medical personnel), dynamic scanning (long acquisition), and expert image analysis
  • Model complexity: selecting the correct compartment model requires prior knowledge; wrong model leads to biased or uninterpretable parameters
  • Partial volume effects: small ROIs (e.g., caudate nucleus) suffer spill-in and spill-out, violating model assumptions and biasing kinetic estimates
  • Input function error: inaccurate arterial sampling, delay calibration, or dispersion modeling propagates large errors into kinetic parameters
  • Statistical noise: late-scan frames have low counts; late-time parameter estimates (k2, k4) have high variance, limiting precision in slow-clearance tissues

Frequently asked

What is the difference between Ki, Bmax, Kd, and DVR?

Ki (net uptake rate) quantifies irreversible tracer accumulation in tissue, reflecting metabolism or trapping. Bmax (maximum binding) and Kd (dissociation constant) describe reversible receptor binding kinetics. DVR (distribution volume ratio) is the ratio of total tissue-to-reference DVs, derived from reversible kinetics; DVR > 1 indicates specific binding. Choice depends on tracer reversibility and study goal.

Why is arterial blood sampling necessary, and can it be avoided?

Arterial sampling measures the plasma tracer input function, essential for compartmental modeling accuracy. Reference tissue models can avoid sampling by using an unaffected brain region as reference, but they require that region to be truly unaffected. In many diseases, finding a truly normal reference region is difficult, so arterial sampling remains the gold standard.

How do I choose between 1-tissue and 2-tissue compartmental models?

The 1-tissue model assumes tracer kinetics driven by delivery and elimination (irreversible). The 2-tissue model adds a slow-equilibrating compartment (reversible binding). Physiological reasoning and statistical model comparison (AIC, Akaike information criterion) guide choice. If arterial TAC rises, tissue TAC follows, and both plateau, 2-tissue is appropriate. If tissue TAC plateaus but arterial TAC falls, 1-tissue suffices.

What is the partial volume effect, and how does it distort kinetic parameters?

Partial volume effect (PVE) occurs when an ROI includes voxels outside the target tissue. Spillover reduces measured activity in small ROIs (e.g., 4-6 mm brain nuclei) and inflates it in reference regions. PVE reduces kinetic parameter magnitude and increases statistical noise. Corrections include post-hoc scaling, scanner-based partial volume correction, or surface-based ROI refinement.

How stable are kinetic parameters across repeated scans?

Intra-subject test-retest variability is 5-15% for Ki (blood flow-limited tracers) and 10-25% for binding parameters. Variability improves with longer acquisitions and careful motion correction. Longitudinal studies typically require 20-30% parameter change to detect true biological change above noise.

Sources

  1. Patlak, C. S., Blasberg, R. G., Fenstermacher, J. D. (1983). Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Journal of Cerebral Blood Flow & Metabolism, 3(1), 1-7. DOI: 10.1038/jcbfm.1983.1 ↗
  2. Logan, J., Fowler, J. S., Christman, D. R., et al. (2000). Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C]cocaine PET studies in human subjects. Journal of Cerebral Blood Flow & Metabolism, 10(5), 740-747. link ↗
  3. Gunn, R. N., Gunn, S. R., Cunningham, V. J. (2001). Positron emission tomography compartmental models. Journal of Cerebral Blood Flow & Metabolism, 21(6), 635-652. DOI: 10.1097/00004647-200106000-00002 ↗

How to cite this page

ScholarGate. (2026, June 3). Positron Emission Tomography Kinetic Modeling. ScholarGate. https://scholargate.app/en/medical-imaging/pet-kinetic-modeling

Related methods

CT Iterative ReconstructionDTI TractographyOCT AngiographyQuantitative Susceptibility MappingRadiomics

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • CT Iterative ReconstructionMedical Imaging↔ compare
  • DTI TractographyMedical Imaging↔ compare
  • OCT AngiographyMedical Imaging↔ compare
  • Quantitative Susceptibility MappingMedical Imaging↔ compare
  • RadiomicsMedical Imaging↔ compare
Compare side by side →

Referenced by

CT Iterative ReconstructionDEXADTI TractographyFunctional UltrasoundImaging Mass CytometryOCT AngiographyQuantitative Susceptibility MappingRadiomics

Similar methods

Pharmacokinetic Compartment ModelPhysiologically Based PharmacokineticsTarget-Mediated Drug DispositionMichaelis-Menten KineticsPopulation PharmacodynamicsScatchard AnalysisPopulation PharmacokineticsDiffusion Kurtosis Imaging

Related reference concepts

Kinetic Parameters and ModelingOne-, Two-, and Multi-Compartment ModelsTissue CompartmentalizationLigand Binding Kinetics and EquilibriumPharmacokinetic Modeling and Half-LifeClinical Pharmacokinetics and Pharmacodynamics

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — PET Kinetic Modeling (Positron Emission Tomography Kinetic Modeling). Retrieved 2026-07-21 from https://scholargate.app/en/medical-imaging/pet-kinetic-modeling · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Christoph Patlak
Subfamily
Quantitative imaging
Year
1983
Type
Mathematical framework for tracer kinetics in PET imaging
Related methods
CT Iterative ReconstructionDTI TractographyOCT AngiographyQuantitative Susceptibility MappingRadiomics
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account